LAMBIASE ALESSIA

Lambiase, A., Spandri, G., Moukham, H., Toini, E., D’Urzo, A., Zecca, G., et al. (In corso di stampa). Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. CURRENT RESEARCH IN FOOD SCIENCE. Dettaglio

Spandri, G., Lambiase, A., Moukham, H., Toini, E., Zecca, G., Grassi, F., et al. (2025). Identification of new sustainable biomolecules with neuroprotective effects: a multifaceted screening of the Mediterranean biodiversity. Intervento presentato a: BtBs day 2025, Milano, Italia. Dettaglio

Moukham, H., Galli, F., Spandri, G., Lambiase, A., Serio, S., Santoro, V., et al. (2025). Glabranin as a natural modulator of AMPK signaling and lipid metabolism in non-alcoholic fatty liver disease. Intervento presentato a: Forum Nazionale della Biodiversità 2025, Milano, Italia. Dettaglio

Lambiase, A., Moukham, H., Spandri, G., Solana-Manrique, C., Paricio, N., Tripodi, F., et al. (2025). Neuroprotective effects of verbascoside on eukaryotic models of Parkinson’s disease. Intervento presentato a: PhD day 2025, Padova, Italia. Dettaglio

Moukham, H., Spandri, G., Lambiase, A., Serio, S., Santoro, V., Piccinelli, A., et al. (2025). Targeting NAFLD via AMPK activation and Lipid droplet clearance: The Role of natural bioactive compounds. Intervento presentato a: SIB "Nutrition and Environment" and "Membrane", Bologna, Italia. Dettaglio